| Compassionate use of remdesivir for patients with severe Covid-19 J Grein, N Ohmagari, D Shin, G Diaz, E Asperges, A Castagna, T Feldt, ... New England Journal of Medicine 382 (24), 2327-2336, 2020 | 3229 | 2020 |
| Epidemic Profile of Shiga-Toxin–Producing Escherichia coli O104:H4 Outbreak in Germany C Frank, D Werber, JP Cramer, M Askar, M Faber, M an der Heiden, ... New England Journal of Medicine 365 (19), 1771-1780, 2011 | 1457 | 2011 |
| Human recombinant soluble ACE2 in severe COVID-19 A Zoufaly, M Poglitsch, JH Aberle, W Hoepler, T Seitz, M Traugott, A Grieb, ... The Lancet Respiratory Medicine 8 (11), 1154-1158, 2020 | 399 | 2020 |
| Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 A Popa, JW Genger, MD Nicholson, T Penz, D Schmid, SW Aberle, ... Science translational medicine 12 (573), eabe2555, 2020 | 223 | 2020 |
| Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority … JM Molina, K Squires, PE Sax, P Cahn, J Lombaard, E DeJesus, MT Lai, ... The lancet HIV 5 (5), e211-e220, 2018 | 162 | 2018 |
| SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses B Agerer, M Koblischke, V Gudipati, LF Montaño-Gutierrez, M Smyth, ... Science immunology 6 (57), eabg6461, 2021 | 153 | 2021 |
| High levels of PAH-metabolites in urine of e-waste recycling workers from Agbogbloshie, Ghana T Feldt, JN Fobil, J Wittsiepe, M Wilhelm, H Till, A Zoufaly, G Burchard, ... Science of the Total Environment 466, 369-376, 2014 | 152 | 2014 |
| Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS‐related lymphoma A Zoufaly, HJ Stellbrink, M Heiden, C Kollan, C Hoffmann, J van Lunzen, ... The Journal of infectious diseases 200 (1), 79-87, 2009 | 152 | 2009 |
| Life after death: posttraumatic stress disorder in survivors of cardiac arrest—prevalence, associated factors, and the influence of sedation and analgesia G Gamper, M Willeit, F Sterz, H Herkner, A Zoufaly, K Hornik, C Havel, ... Critical care medicine 32 (2), 378-383, 2004 | 135 | 2004 |
| Late presentation for HIV diagnosis and care in G ermany A Zoufaly, M An der Heiden, U Marcus, C Hoffmann, HJ Stellbrink, L Voss, ... HIV medicine 13 (3), 172-181, 2012 | 134 | 2012 |
| Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients E Puchhammer-Stöckl, I Görzer, A Zoufaly, P Jaksch, CC Bauer, ... Transplantation 81 (2), 187-194, 2006 | 101 | 2006 |
| ACE2 elevation in severe COVID-19 R Reindl-Schwaighofer, S Hödlmoser, F Eskandary, M Poglitsch, ... American journal of respiratory and critical care medicine 203 (9), 1191-1196, 2021 | 97 | 2021 |
| Pharmacokinetics of lopinavir and ritonavir in patients hospitalized with coronavirus disease 2019 (COVID-19) C Schoergenhofer, B Jilma, T Stimpfl, M Karolyi, A Zoufaly Annals of internal medicine 173 (8), 670-672, 2020 | 91 | 2020 |
| Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19 H Vietzen, A Zoufaly, M Traugott, J Aberle, SW Aberle, ... Genetics in Medicine 23 (5), 963-967, 2021 | 90 | 2021 |
| Increase in human West Nile and Usutu virus infections, Austria, 2018 SW Aberle, J Kolodziejek, C Jungbauer, K Stiasny, JH Aberle, A Zoufaly, ... Eurosurveillance 23 (43), 1800545, 2018 | 90 | 2018 |
| Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy A Zoufaly, M An Der Heiden, C Kollan, JR Bogner, G Fätkenheuer, ... Journal of Infectious Diseases 203 (3), 364-371, 2011 | 85 | 2011 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 81 | 2021 |
| Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study P Schommers, C Wyen, M Hentrich, D Gillor, A Zoufaly, B Jensen, ... Aids 27 (5), 842-845, 2013 | 74 | 2013 |
| Dynamics of CD4 T cell and antibody responses in COVID-19 patients with different disease severity M Koblischke, MT Traugott, I Medits, FS Spitzer, A Zoufaly, ... Frontiers in medicine 7, 592629, 2020 | 67 | 2020 |
| Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon T Feldt, FS Sarfo, A Zoufaly, RO Phillips, G Burchard, J van Lunzen, ... Journal of clinical virology 58 (1), 18-23, 2013 | 67 | 2013 |
